Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1129160

	registered interest
	date	03/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps is he taking to ensure the adequacy of supplies of flu vaccine for autumn 2019.
	tabling member constituency	Warley
	tabling member printed	John Spellar
	uin	258987
	answer	answer is ministerial correction date of answer 11/06/2019 answer text <p>Public Health England (PHE) provides flu vaccines centrally for the children’s flu programme. Sufficient vaccine has been procured to ensure that all eligible children who present for vaccination can be offered the appropriate vaccine.</p><p>General practitioners and other providers are directly responsible for ordering flu vaccine from suppliers which are used to deliver the national flu programme to the other eligible groups. PHE and NHS England maintain oversight at a national level to help facilitate a constant supply of vaccine.</p><p> </p><p><strong> </strong></p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 11/06/2019 16:27:41 answering member 4455 label Biography information for Seema Kennedy
	tabling member	318 label Biography information for John Spellar

1131830

	registered interest
	date	12/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Fungal Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the risks to patient health posed by fungal infections; and what steps he is taking to tackle those risks.
	tabling member constituency	Warley
	tabling member printed	John Spellar
	uin	263692
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>The most common invasive fungal infection in the United Kingdom is blood stream infection with yeast, often following surgical interventions. Public Health England (PHE) has prepared advisory documentation for national dissemination and individual hospital response following recent outbreaks caused by this organism, which can be viewed at the following link:</p><p><a href="https://www.gov.uk/government/publications/candida-auris-emergence-in-england/candida-auris-within-the-united-kingdom-updated-guidance-published" target="_blank">https://www.gov.uk/government/publications/candida-auris-emergence-in-england/candida-auris-within-the-united-kingdom-updated-guidance-published</a></p><p>Invasive mould infections such as invasive aspergillosis are more often seen in patients with haematological malignancies or those undergoing treatment for them, and it is difficult to capture absolute data on the incidence of these due to difficulty in definitive diagnosis.</p><p>Chronic yeast infections are frequently seen in females that have suffered recurrent bouts of vaginal candidosis (thrush). Estimates suggest that 70% of women report having had at least one episode whilst 8% have repeated and persistent infections. Dermatophyte infections, including athletes’ foot are extremely common, found in about 10% of the adult population at any one time. Scalp and nail infections with these organisms are more disfiguring and difficult to treat.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 20/06/2019 15:39:41 answering member 4455 label Biography information for Seema Kennedy
	tabling member	318 label Biography information for John Spellar

1177332

	registered interest
	date	10/02/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Contraceptives: Shortages
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reasons there is a shortage of contraceptive drugs; what steps his Department is taking to tackle that shortage; and what lessons his Department has learnt to prevent a shortage of contraceptive drugs in the future.
	tabling member constituency	Warley
	tabling member printed	John Spellar
	uin	14604
	answer	answer is ministerial correction date of answer 13/02/2020 answer text <p>We are aware of manufacturing problems affecting supply of a limited number of contraceptive preparations. Most contraceptive medicines and products remain available, including alternatives to those experiencing supply issues.</p><p>We have been working closely with affected suppliers of contraceptive medicines to maintain overall supply to patients and have provided regular updates about the supply issues and management advice to the National Health Service.</p><p>We understand the importance of maintaining access to contraceptives medicines to people in this country and are working with all relevant stakeholders to resolve the supply issues as soon as possible. We will continue to monitor the supply situation closely and to work with all suppliers to put contingency measures in place to ensure a continued supply of these products.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 13/02/2020 17:02:50 answering member 4380 label Biography information for Jo Churchill
	tabling member	318 label Biography information for John Spellar

1193079

	registered interest
	date	05/05/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Protective Clothing: Manufacturing Industries
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to incentivise companies to use their manufacturing facilities to produce personal protective equipment during the covid-19 outbreak.
	tabling member constituency	Warley
	tabling member printed	John Spellar
	uin	43592
	answer	answer is ministerial correction date of answer 22/05/2020 answer text <p>As of 15 May, over 13,000 businesses have contacted the Government with offers of help on supplying personal protective equipment (PPE). Many are related to the manufacture of PPE for the National Health Service and care sectors, a vast majority of which we are taking forward, predominantly from United Kingdom based companies but also including multinational companies. Some offers were not progressed due to financial and capability considerations.</p><p>The Department engages directly with potential manufacturers to qualify and prioritise the opportunity, based on availability of/access to raw supplies, lead-times to manufacture, and other commercial considerations. Product prototypes are submitted to a Technical Product Review process, to ensure they meet essential health, safety and quality standards for PPE. Financial due diligence and fraud prevention measures are also undertaken, after which the Department can contract with the manufacturer.</p><p>Lord Deighton is leading the Government’s efforts to secure sufficient PPE and ensure this gets to where it is needed. He is also driving forward coordination of the end-to-end process design and manufacture of new domestic PPE supplies. As at 15 May, the Department has entered into contract and placed orders with 8 manufacturers to provide millions of items of PPE products to the National Health Service and carers. The volumes will increase in the coming weeks. Details of this work can be found at the following links:</p><p><a href="https://www.gov.uk/government/news/millions-more-items-of-ppe-for-frontline-staff-from-new-business-partnerships" target="_blank">https://www.gov.uk/government/news/millions-more-items-of-ppe-for-frontline-staff-from-new-business-partnerships</a></p><p><a href="https://www.gov.uk/government/news/70-million-face-masks-for-nhs-and-care-workers-through-new-industry-deal" target="_blank">https://www.gov.uk/government/news/70-million-face-masks-for-nhs-and-care-workers-through-new-industry-deal</a></p><p /><p /> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 22/05/2020 10:56:55 answering member 4380 label Biography information for Jo Churchill
	tabling member	318 label Biography information for John Spellar

1201989

	registered interest
	date	09/06/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps is his Department taking to prevent the NHS being overcharged for off-patent drugs.
	tabling member constituency	Warley
	tabling member printed	John Spellar
	uin	57086
	answer	answer is ministerial correction date of answer 24/06/2020 answer text <p>The costs of branded medicines, whether they have patents on them or not, are controlled by the 2019 Voluntary Scheme for Branded Medicines Pricing and Access and the statutory scheme for branded medicines.</p><p>For unbranded generic medicines the Department relies on competition to keep prices down. This has led to some of the lowest prices in Europe and allows prices to react to the market. In an international market this ensures that when demand is high and supply is low, prices in the United Kingdom can increase to help secure the availability of medicines for UK patients. Concerns about potential drug pricing abuses are a matter for the Competition and Markets Authority (CMA). Where it has concern about the price of a generic medicines, the Department asks the CMA to investigate that price. The CMA has several ongoing investigations into excessive prices of generic medicines.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 24/06/2020 12:46:42 answering member 4380 label Biography information for Jo Churchill
	tabling member	318 label Biography information for John Spellar

1228802

	registered interest
	date	28/08/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much his Department has budgeted for the 2020-21 flu vaccination campaign; how many doses have been ordered; and from (a) which companies and (b) where the vaccines will be produced.
	tabling member constituency	Warley
	tabling member printed	John Spellar
	uin	81513
	answer	answer is ministerial correction date of answer 23/09/2020 answer text <p>Public Health England’s media spend for the 2020 - 2021 influenza vaccination campaign budget is £4.15 million. The Department has agreed to procure 7.65 million additional doses of seasonal flu vaccine to date and continues to work with suppliers to increase the size of this additional stock. This is in addition to the stock that general practitioners and pharmacists have ordered directly from manufacturers for the adult programme.</p><p>The contracts for the additional vaccine are with Aventis Pharma Limited (T/A Sanofi), Mylan UK Healthcare Ltd, GlaxoSmithKline UK Ltd and Seqirus UK Ltd.</p><p>Production of the vaccine will include a number of processes. Some aspects include processing in the United Kingdom and some overseas.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 23/09/2020 13:48:30 answering member 4380 label Biography information for Jo Churchill previous answer version 44268 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	318 label Biography information for John Spellar

1232804

	registered interest
	date	09/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Laboratories: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what laboratory capacity in universities and colleges he has secured for covid-19 testing.
	tabling member constituency	Warley
	tabling member printed	John Spellar
	uin	87479
	answer	answer is ministerial correction date of answer 08/03/2021 answer text <p>We do not publish data on individual laboratory capacities. We have six Lighthouse Laboratories operating with a range of partners across the United Kingdom at Milton Keynes, Alderley Park, Glasgow, Cambridge, Newport and Charnwood. We have additional Lighthouse Laboratories in Newcastle, Brant’s Bridge and Plymouth opening over the coming months.</p><p> </p><p>In addition to the growing Lighthouse Laboratory network, there are partnership agreements with the public, private and academic sectors. This includes Antrim Laboratory in Northern Ireland, and partner laboratories at Birmingham University, Imperial College London, Queen Mary University of London, Kings Health Partners and a partnership between Health Services Laboratories and University College London.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 08/03/2021 16:02:28 answering member 4527 label Biography information for Helen Whately previous answer version 47036 answering member constituency Faversham and Mid Kent answering member printed Helen Whately answering member 4527 label Biography information for Helen Whately
	tabling member	318 label Biography information for John Spellar

1232806

	registered interest
	date	09/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Laboratories: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much laboratory testing capacity in industry he has secured for covid-19 testing.
	tabling member constituency	Warley
	tabling member printed	John Spellar
	uin	87480
	answer	answer is ministerial correction date of answer 25/11/2020 answer text <p>Testing capacity is published on GOV.UK but is not broken down by sector. On 4 November 2020, testing capacity was 521,016.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 25/11/2020 13:55:09 answering member 4527 label Biography information for Helen Whately previous answer version 47038 answering member constituency Faversham and Mid Kent answering member printed Helen Whately answering member 4527 label Biography information for Helen Whately
	tabling member	318 label Biography information for John Spellar

1234434

	registered interest
	date	15/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Members: Correspondence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when he plans to respond to the correspondence of 17 June 2020 from the hon. Member for Warley on his constituent Sally Taylor.
	tabling member constituency	Warley
	tabling member printed	John Spellar
	uin	90040
	answer	answer is ministerial correction date of answer 07/10/2020 answer text <p>The Department replied to the Rt hon. Member’s letter on 23 September 2020.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 07/10/2020 11:41:52 answering member 4362 label Biography information for Edward Argar
	tabling member	318 label Biography information for John Spellar

1235999

	registered interest
	date	22/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many cases of acute respiratory infections which resulted in at least one positive test for covid-19 there were in the most recent week for which figures are available; and what proportion of those cases occurred in (a) care homes, (b) the workplace, (c) education settings and (d) pubs and food outlets.
	tabling member constituency	Warley
	tabling member printed	John Spellar
	uin	92626
	answer	answer is ministerial correction date of answer 12/10/2020 answer text <p>Public Health England publishes the number of acute respiratory infections reported each week in the national COVID-19 surveillance reports.</p><p>729 new incidents of acute respiratory infection were reported in week 37 (Week commencing 7 August 2020).</p><p>Of these, 313 incidents were from care homes where 228 had at least one linked case that tested positive for SARS-CoV-2; 110 incidents were from workplace settings where 92 had at least one linked case that tested positive for SARS-CoV-2; 193 incidents were from educational settings where 110 had at least one linked case that tested positive for SARS-CoV-2; 34 incidents were from food outlet/restaurant settings where 25 had at least one linked case that tested positive for SARS-CoV-2; four incidents were from prisons where three had at least one linked case that tested positive for SARS-CoV-2; 18 incidents were from hospitals where 13 had at least one linked case that tested positive for SARS-CoV-2; and 57 incidents were from other settings where 39 had at least one linked case that tested positive for SARS-CoV-2.</p><p>The most recent weekly COVID-19 surveillance report can be found at the following link:</p><p><a href="https://www.gov.uk/government/publications/national-covid-19-surveillance-reports" target="_blank">https://www.gov.uk/government/publications/national-covid-19-surveillance-reports</a></p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 12/10/2020 11:06:38 answering member 4527 label Biography information for Helen Whately previous answer version 50058 answering member constituency Faversham and Mid Kent answering member printed Helen Whately answering member 4527 label Biography information for Helen Whately
	tabling member	318 label Biography information for John Spellar